Financials

  • Market Capitalization 5.56 M
  • Employee 3
  • Founded 2010
  • CEO N/A
  • Website www.silopharma.com
  • Headquarter Nevada, United States
  • FIGI BBG002D1DZ06
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.06
Rapporto prezzo/fatturato
43.51

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4940
APVO
Aptevo Therapeutics Inc. - Common Stock
4.62 USD+11.33%+1.99%-0.43%-31.56%5.76 M USD
4943
ADIL
Adial Pharmaceuticals, Inc - Common Stock
2.65 USD-6.36%-7.67%-5.36%+597.37%5.68 M USD
4950
SNGX
Soligenix, Inc. - Common Stock
0.37 USD+5.71%-2.63%-15.91%-67.26%5.48 M USD
4951
NCNA
NuCana plc - American Depositary Shares
1.31 USD+2.34%-6.43%-33.16%-39.07%5.45 M USD

Notizie